Amy Attaway, MD
Cleveland Clinic Main Campus
Specialty in Diseases & Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- End Stage Lung Disease
- General Pulmonary Medicine
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
About Amy Attaway, MD
Amy Attaway, MD is a staff member in the Respiratory Institute at Cleveland Clinic's main campus with a primary appointment in the Pulmonary Dept and a joint appointment in Critical Care Medicine.
Her clinical interests include COPD, asthma, bronchiectasis, and general (diagnostic) pulmonary medicine.
Dr. Attaway received her medical degree from University at Buffalo School of Medicine in 2011. She completed internal medicine residency at Western Michigan University School of Medicine and pulmonary and critical care fellowship at University Hospital of Cleveland. She has current board certification in internal medicine and pulmonary medicine. Dr. Attaway is a member of the American Thoracic Society and Chest. Her research interests include COPD, asthma and high flow nasal cannula.
Education & Professional Highlights
Education & Fellowships
Fellowship - University Hospitals of Cleveland Health System
Pulmonary & Critical Care Medicine
Cleveland, OH USA
Residency - Western Michigan University
Kalamazoo, MI USA
Medical Education - State University of New York at Buffalo
Buffalo, NY USA
Undergraduate - University of Notre Dame
Notre Dame, IN USA
- Internal Medicine - Critical Care Medicine
- Internal Medicine - Pulmonary Disease
- Internal Medicine
Critical Care Specialists; Pulmonologists
Research & Publications
See publications for Amy Attaway, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/24/2022, Dr. Attaway has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.